Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C482748-50 50 µl (1 mg/ml) $286 
LS-C482748-100 100 µl (1 mg/ml) $321 
LS-C482748-200 200 µl (1 mg/ml) $386 
EIF3C / EIF3S8 Antibody - Immunofluorescent analysis of eIF3C staining in U2OS cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
EIF3C / EIF3S8 Antibody - Western blot analysis of eIF3C expression in HepG2 (A); SW620 (B); mouse testis (C) whole cell lysates.
EIF3C / EIF3S8 Antibody - Immunofluorescent analysis of eIF3C staining in U2OS cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
EIF3C / EIF3S8 Antibody - Western blot analysis of eIF3C expression in HepG2 (A); SW620 (B); mouse testis (C) whole cell lysates.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human EIF3C / EIF3S8 Antibody (IF, WB) LS‑C482748

Polyclonal Rabbit anti‑Human EIF3C / EIF3S8 Antibody (IF, WB) LS‑C482748

Antibody:
EIF3C / EIF3S8 Rabbit anti-Human Polyclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Price
Catalog Number
$286
LS-C482748-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
EIF3C / EIF3S8 Rabbit anti-Human Polyclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified

Specifications

Description
EIF3S8 antibody LS-C482748 is an unconjugated rabbit polyclonal antibody to EIF3S8 (EIF3C) from human. It is reactive with human, mouse and rat. Validated for ICC, IF and WB.
Target
Human EIF3C / EIF3S8
Synonyms
EIF3C | EIF3 p110 | EIF3S8 | EIF3-P110
Host
Rabbit
Reactivity
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
Recombinant full length Human EIF3C.
Specificity
Recognizes endogenous levels of eIF3C protein.
Applications
  • ICC (1:50 - 1:100)
  • Immunofluorescence (1:50 - 1:100)
  • Western blot (1:500 - 1:2000)
Presentation
PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
Storage
Aliquot and store at -20°C for 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About EIF3C / EIF3S8
Q99613 NM_003752 NP_003743.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/29/2024